NCCS Develops AI Tool to Predict Liver Cancer Recurrence After Surgery
oncodaily - National Cancer Centre Singapore (NCCS) shared on LinkedIn: “Can we now predict who’s at greatest risk for liver cancer recurrence? Congratulations to NCCS’ Professor Pierce Chow, Associate Professor Wai Leong Tam, Mr. Karthik Sekar, […]
AI Summary: A newly developed AI model predicts risk of liver cancer recurrence following surgical resection, integrating imaging and clinical variables to stratify patients more accurately. Early validation suggests the tool could personalize surveillance intensity and adjuvant therapy decisions, reducing unnecessary exams for low‑risk patients while focusing resources where recurrence risk is highest.
Related Stories
AI face photos may predict cancer survival years earlier / 3 months
Repeat PSMA PET scans change prostate cancer care for many patients / 6 wks
FDA clears blood test to guide breast cancer therapy choices / 3 months
Deep‑learning pathomics platform may predict immunotherapy response in lung cancer / 4 months
AI model generalizes to predict immunotherapy response across cancers / 1 month
Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 5 months
Grail names new CEO as Bob Ragusa retires / 5 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Pediatric Oncology, FDA, Corporate Takeover, Food Safety and look for the RSS link.
StackHealth Time Machine